
|Videos|November 16, 2015
Medication Management in Inflammatory Bowel Disease
Author(s)Davy James, Managing Editor
Marc O'Connor, chief operating officer of Curant Health, discusses counseling patients on a therapeutic regimen for IBD.
Advertisement
Marc O'Connor, chief operating officer of Curant Health, discusses counseling patients on a therapeutic regimen for IBD.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Guiding Patients With Sickle Cell Disease Through the Transformative Era of Gene Therapy
2
New Data Highlights Pharmacists’ Expanding Roles in Hematologic Malignancies
3
Bridging Response Emerges as Key Predictor of Cilta-Cel Outcomes in CARTITUDE-4
4
Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
5

















































































































































































































